SCHEMBL1769969

SCHEMBL1769969

O=C(Cl)c1ccc2cc(F)ccc2c1.O=C(O)c1ccc2cc(F)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
BCL2L1 Q07817 1/20 0.46
BAD Q92934 1/20 0.46
PTPN1 P18031 1/20 0.44
TSHR P16473 2/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 3/20 0.41
PDPK1 O15530 1/20 0.41
LMNA P02545 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41
NR4A2 P43354 2/20 0.40
HCAR1 Q9BXC0 1/20 0.40
ENPP2 Q13822 1/20 0.40
RARA P10276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12520344 0.93 CYP1A2 (0.46) KDM4EBCL2L1BADTSHRALDH1A1
SCHEMBL29766531 0.91 KDM4E (0.55) KDM4EBCL2L1BADPTPN1TSHR
SCHEMBL1285483 0.91 KDM4E (0.55) KDM4EBCL2L1BADPTPN1TSHR
SCHEMBL7358277 0.89 KDM4E (0.57) KDM4EPTPN1TSHRALDH1A1HPGD
SCHEMBL6415513 0.85 BCL2L1 (0.52) KDM4EBCL2L1BADPTPN1TSHR
SCHEMBL14829725 0.83 KDM4E (0.50) KDM4EPTPN1TSHRALDH1A1HPGD
SCHEMBL727139 0.80 CES2 (0.52) KDM4EPTPN1TSHRALDH1A1HPGD
SCHEMBL29375279 0.80 CES2 (0.52) KDM4EPTPN1TSHRALDH1A1HPGD
SCHEMBL6916181 0.78 KDM4E (0.68) KDM4EPTPN1TSHRALDH1A1HPGD
SCHEMBL18758 0.78 KDM4E (0.68) KDM4EPTPN1TSHRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011061168-A1 ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2011-05-26 WO disclosed